Reuters first on $6.5 bln ImClone bid by Eli Lilly

Reuters beat Bloomberg and Dow Jones by roughly seven hours with news on Oct. 6 that ImClone Systems Inc. had agreed to be acquired by Eli Lilly and Co for $6.5 billion, beating out Bristol-Myers Squibb and ending a colorful takeover tussle that involved style guru Martha Stewart and corporate raider Carl Icahn. ImClone shares rose 4 percent. Bloomberg picked up the Reuters report, analysts in Europe cited the report, and ImClone and Lilly announced the deal in a press release nearly 7 hours later.